SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

HC Wainwright & Co. Maintains Buy on Avenue Therapeutics, Raises Price Target to $13

HC Wainwright & Co. maintains Avenue Therapeutics (NASDAQ:ATXI) with a Buy and raises the price target from $12 to $13.

Benzinga · 05/12/2020 11:46

HC Wainwright & Co. maintains Avenue Therapeutics (NASDAQ:ATXI) with a Buy and raises the price target from $12 to $13.